Erasca (ERAS)
Develops pan-RAS and pan-KRAS therapies for RAS/MAPK-driven solid tumors.
$15.55
After hours+0.01 (+0.03%)
At close$15.55(+3.36%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 79.08% | 276.59M shares | |
|---|---|---|---|
| 274 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 0.14% | 477.9K shares | |
| 3 holders · as of Apr 3, 2026 | |||
| Other | ≈ 20.78% | 72.70M shares | |
| remainder | |||
349.76M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
274 holders · 276.59M shares · 65 new positions · 166 increased · 80 reduced · 31 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 24.98M | 7.14% | +300.0K | Aug 14, 2026 |
| T. Rowe Price Investment Management, Inc. | 21.19M | 6.06% | −73.8K | Aug 14, 2026 |
| BlackRock, Inc. | 21.15M | 6.05% | +1.00M | Aug 7, 2026 |
| RTW Investments, LP | 17.95M | 5.13% | +1.79M | Aug 14, 2026 |
| VR Adviser, LLC | 17.89M | 5.12% | +1.51M | Aug 14, 2026 |
| State Street Corp | 12.18M | 3.48% | +2.88M | Aug 7, 2026 |
| Logos Global Management LP | 12.15M | 3.47% | +1.00M | Aug 14, 2026 |
| Vanguard Capital Management LLC | 11.40M | 3.26% | +152.5K | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 6.80% | 21.22M | 13G | May 15, 2026 |
| BlackRock, Inc. | 5.40% | 15.36M | Nov 8, 2024 | |
| Venrock Healthcare Capital Partners III, L.P. | 5.30% | 16.38M | 13G | May 15, 2026 |
| Frazier Life Sciences Public Fund, L.P. | 5.30% | 15.04M | 13G | Aug 14, 2025 |
| RTW Investments, LP | 5.20% | 16.16M | 13G | May 15, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Apr 1, 2026 | Ebun Garnerofficer: Chief Legal Officer | Sale | 80,000 | $16.40 | 25,076 |
| Mar 4, 2026 | Shannon Morrisofficer: Chief Medical Officer | Sale | 20,000 | $15.04 | 0 |
| Jan 7, 2026 | Ebun Garnerofficer: General Counsel & Corp. Sec. | Sale | 120,000 | $5.59 | 25,076 |
House and Senate disclosures
Not reported.